00000nam 2200000zi 4500 9.944589 CaOODSP 20241206084526 m o d f cr cn |||||||| 241029e202410 onc ob f000 0 eng d 9780660742267 CaOODSP eng rda CaOODSP n-cn--- H164-383/2024E-PDF Guidance on advertising nicotine replacement therapies. Ottawa, ON : Health Canada = Santé Canada, October 2024. ©2024 1 online resource (iii, 11 pages) text txt rdacontent computer c rdamedia online resource cr rdacarrier Issued also in French under title: Lignes directrices sur la publicité pour les thérapies de remplacement de la nicotine. "Pub.: 240592." Includes bibliographical references (page 11). "This guidance document will help industry meet their advertising-related obligations under the Supplementary Rules Respecting Nicotine Replacement Therapies Order (the Order). This document also gives guidance to Health Canada staff on how relevant mandates and objectives should be met fairly, consistently and effectively. Advertising preclearance agencies may use this guidance to inform their internal practices and the services they provide to industry"--Purpose, page 1. Smoking cessation Law and legislation Canada. Smoking cessation products Government policy Canada. Canada. Health Canada, issuing body. Lignes directrices sur la publicité pour les thérapies de remplacement de la nicotine. (CaOODSP)9.944590 PDF 434 KB https://publications.gc.ca/collections/collection_2024/sc-hc/H164-383-2024-eng.pdf HTML N/A https://www.canada.ca/en/health-canada/services/drugs-health-products/regulatory-requirements-advertising/policies-guidance-documents/advertising-nicotine-replacement-therapies.html